Side-by-side financials for ADVB and EXAS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADVB | EXAS |
|---|---|---|
| Market cap | - | $20.03 B |
| US-listed rank | - | #619 |
| Revenue (latest FY) | - | $3.25B |
| Net income (latest FY) | -$3.26M | -$207.95M |
| Net margin | - | -6.4% |
| SEC filings | 87 | 1,834 |
Full pages: Advanced Biomed Inc. and EXACT SCIENCES CORP, or browse the full rankings.